Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05105802Not ApplicableCompleted

Mindfulness-Based Intervention for Mild Traumatic Brain Injury

Role: collaborator

NCT05028179Not ApplicableUnknown

PROTEUS: Evaluating the Use of Artificial Intelligence to Support Stress Echocardiography Testing for Heart Disease

Role: collaborator

NCT05378243Not ApplicableUnknown

Innovative Robotic Gait Trainer Use to Enable Walking in Children With Cerebral Palsy GMFCS III and IV

Role: collaborator

NCT03514628Not ApplicableCompleted

Evaluation of the Valsalva Assist Device to Treat SVT

Role: collaborator

NCT02311751Not ApplicableCompleted

rTMS for Executive Function Deficits in Autism Spectrum Disorder

Role: collaborator

NCT01581606Completed

Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes

Role: collaborator

NCT02898467Unknown

Atherothrombosis Markers in Diabetics

Role: collaborator

NCT02137213Phase 2Completed

Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation

Role: collaborator

All 8 trials loaded